Detailed price information for Lowe's Companies (LOW-N) from The Globe and Mail including charting and trades.

Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.

Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...